David McClung, CFO of BioCardia Inc. ($BCDA), made two open market purchases totaling about $35,000 in the last year, with the latest on June 30, 2025. His activity ranks 3,315th among nearly 5,000 insiders, below the average of $1.5 million per buyer and 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 58276 | $1.37 | 106,226.0000 | 10,612,734 | 121.53% | 0.55% |
| Dec. 8, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Stock Option (right to buy) | 27000 | $0.00 | 46,340.0000 | 10,612,734 | 139.61% | 0.25% |
| Dec. 8, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | F | Common Stock | 29339 | $1.37 | 76,887.0000 | 10,612,734 | 61.70% | 0.28% |
| June 30, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | P | Common Stock | 4819 | $2.08 | 47,950.0000 | 4,680,005 | 11.17% | 0.10% |
| June 30, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | P | Warrant (right to buy) | 4819 | $0.00 | 26,275.0000 | 4,680,005 | 22.46% | 0.10% |
| April 23, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | P | Warrant (right to buy) | 13123 | $0.00 | 21,456.0000 | 4,680,005 | 157.48% | 0.28% |
| April 23, 2025 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | P | Common Stock | 13123 | $1.91 | 43,131.0000 | 4,680,005 | 43.73% | 0.28% |
| Oct. 11, 2024 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | F | Common Stock | 11565 | $2.65 | 30,008.0000 | 0 | 27.82% | 0.00% |
| Oct. 11, 2024 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 24193 | $2.65 | 41,573.0000 | 0 | 139.20% | 0.00% |
| Sept. 3, 2024 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Warrant (right to buy) | 8333 | $0.00 | 8,333.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 8333 | $3.00 | 17,380.0000 | 0 | 92.11% | 0.00% |
| June 23, 2023 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 4280 | $2.34 | 135,724.0000 | 0 | 3.26% | 0.00% |
| May 31, 2023 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | F | Common Stock | 20676 | $1.77 | 131,444.0000 | 0 | 13.59% | 0.00% |
| May 18, 2023 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Stock Option (right to buy) | 68265 | $0.00 | 68,265.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 61389 | $1.70 | 152,120.0000 | 0 | 67.66% | 0.00% |
| May 12, 2022 | BioCardia, Inc. | $BCDA | McClung David | Chief Financial Officer | A | Common Stock | 17347 | $1.32 | 79,803.0000 | 0 | 17.86% | 0.00% |